Krystal Biotech reported cash from operations of $74.79M and free cash flow of $71.22M for the quarter ended Jun 2026, up 41.8% year over year. This cash flow statement covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||
| Net Income | -15.64M | -22.02M | -51.26M | -29.10M | -31.38M | -28.24M | -48.25M | -33.21M | 80.75M | 8.69M | 0.93M | 15.57M | 27.17M | 45.51M | 35.70M | 38.33M | 79.37M | 51.39M | 55.93M | 54.77M | ||||||||||||||||||||
| Share-based CompensationStock Comp. | 3.67M | 5.14M | 6.43M | 8.19M | 9.06M | 9.55M | 10.44M | 11.33M | 8.31M | 9.85M | 9.30M | 13.16M | 13.32M | 13.36M | 13.48M | 14.12M | 13.15M | 13.76M | 13.61M | 14.16M | ||||||||||||||||||||
| Deferred Taxes | -1.83M | |||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -7.25M | -20.90M | -15.49M | -43.06M | -19.69M | -22.33M | -26.16M | -34.19M | -21.23M | -7.23M | 15.89M | -4.17M | 58.86M | 52.84M | 30.97M | 52.73M | 39.66M | 77.51M | 80.38M | 74.79M | ||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.22M | 0.22M | 0.23M | 0.23M | 0.18M | 0.19M | 0.19M | 0.19M | 0.22M | 0.19M | 0.21M | 0.20M | 0.20M | 0.21M | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.78M | 0.78M | 1.01M | 0.98M | 0.97M | 1.09M | 0.70M | 1.04M | 0.83M | |||||||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 9.32M | 32.72M | 4.43M | 56.77M | -5.94M | 7.45M | -1.49M | 8.18M | 17.92M | -2.49M | -0.06M | 11.97M | ||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | 0.91M | 3.08M | 0.49M | 2.24M | -0.53M | 3.68M | 6.52M | 1.40M | -0.88M | 4.71M | 1.06M | 0.24M | 0.96M | |||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.46M | 0.94M | -0.55M | 0.58M | -0.34M | -0.94M | 0.11M | 0.37M | -0.36M | -0.22M | 0.73M | 0.78M | 0.09M | -0.59M | 0.91M | 4.12M | -4.02M | -0.18M | 1.02M | 3.06M | ||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 3.93M | -4.02M | 2.01M | 0.46M | 0.54M | 2.16M | -3.46M | 1.80M | 2.54M | 3.68M | -5.16M | 1.13M | 1.94M | 7.48M | 3.69M | -1.29M | 5.92M | 5.79M | -6.31M | 5.44M | ||||||||||||||||||||
| Change in TaxesChange Taxes | 0.97M | -0.46M | 1.41M | 9.15M | 2.29M | -3.37M | 4.67M | |||||||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 17.31M | 40.88M | 17.19M | 16.52M | 14.06M | 5.22M | 11.87M | -0.87M | 0.10M | 0.70M | 8.46M | 0.11M | -0.28M | 0.20M | 6.20M | 1.90M | 1.70M | 2.14M | 7.15M | 3.56M | ||||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.43M | |||||||||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 8.07M | 21.00M | 24.04M | 62.79M | 66.77M | 104.08M | 154.52M | 161.23M | 112.87M | 74.59M | 63.62M | 95.18M | 79.25M | 60.49M | 88.81M | 105.28M | 95.79M | 85.76M | 103.60M | 100.00M | ||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -37.17M | -126.54M | -55.91M | -38.22M | -14.74M | -5.21M | 3.56M | -15.96M | 105.19M | -10.16M | -25.98M | -19.35M | -34.33M | -83.78M | -54.77M | -10.53M | -4.29M | 11.16M | -63.58M | -161.58M | ||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 2.22M | 25.43M | 13.51M | 2.61M | 15.97M | 10.64M | 3.37M | 2.43M | 1.46M | 1.80M | 3.71M | 15.69M | 6.50M | 15.16M | ||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.51M | 202.07M | -0.54M | 30.70M | 2.12M | 3.07M | 1.47M | 185.27M | 13.39M | 2.62M | 10.58M | 10.64M | 3.37M | 2.43M | -12.47M | 1.80M | 3.71M | 15.67M | -10.46M | 15.05M | ||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | ||||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 1.51M | 202.07M | 0.11M | 30.70M | 2.12M | -3.94M | 2.22M | 157.62M | -0.12M | 0.01M | ||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.04M | -0.04M | 0.01M | 0.01M | -0.14M | 0.19M | -0.34M | 0.29M | -0.59M | 0.17M | 1.06M | -0.31M | -0.64M | -1.33M | -1.83M | |||||||||||||||||||||||||
| Change in Cash | -42.91M | 54.63M | -71.94M | -50.58M | -32.31M | -24.51M | -21.16M | 135.13M | 97.37M | -14.91M | 0.68M | -13.22M | 28.18M | -29.10M | -36.09M | 45.06M | 38.77M | 103.70M | 5.01M | -73.57M | ||||||||||||||||||||
| Free Cash FlowFCF | -24.57M | -61.78M | -32.68M | -59.57M | -33.74M | -27.55M | -38.02M | -33.32M | -21.33M | -7.93M | 7.43M | -4.28M | 59.13M | 52.64M | 24.77M | 50.83M | 37.95M | 75.37M | 73.23M | 71.22M | ||||||||||||||||||||
| Net Cash FlowNCF | -42.91M | 54.63M | -71.94M | -50.58M | -32.31M | -24.47M | -21.12M | 135.12M | 97.35M | -14.77M | 0.49M | -12.88M | 27.89M | -28.51M | -36.27M | 44.00M | 39.08M | 104.34M | 6.34M | -71.74M |